BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 8174675)

  • 1. Mutation in the negative regulatory element of the erythropoietin receptor gene in a case of sporadic primary polycythemia.
    Sokol L; Prchal JF; D'Andrea A; Rado TA; Prchal JT
    Exp Hematol; 1994 May; 22(5):447-53. PubMed ID: 8174675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The erythropoietin receptor gene is not linked with the polycythemia phenotype in a family with autosomal dominant primary polycythemia.
    Kralovics R; Sokol L; Broxson EH; Prchal JT
    Proc Assoc Am Physicians; 1997 Nov; 109(6):580-5. PubMed ID: 9394420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycythemia and oxygen sensing.
    Maran J; Prchal J
    Pathol Biol (Paris); 2004 Jun; 52(5):280-4. PubMed ID: 15217714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Missense mutation of the erythropoietin receptor is a rare event in human erythroid malignancies.
    Le Couedic JP; Mitjavila MT; Villeval JL; Feger F; Gobert S; Mayeux P; Casadevall N; Vainchenker W
    Blood; 1996 Feb; 87(4):1502-11. PubMed ID: 8608241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin-independent erythroid colony formation by bone marrow progenitors exposed to interleukin-11 and interleukin-8.
    Corre-Buscail I; Pineau D; Boissinot M; Hermouet S
    Exp Hematol; 2005 Nov; 33(11):1299-308. PubMed ID: 16263414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Benign erythrocytosis" and other familial and congenital polycythemias.
    Prchal JT; Sokol L
    Eur J Haematol; 1996 Oct; 57(4):263-8. PubMed ID: 8982288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons from familial myeloproliferative disorders.
    Skoda R; Prchal JT
    Semin Hematol; 2005 Oct; 42(4):266-73. PubMed ID: 16210040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gene encoding hematopoietic cell phosphatase (SHP-1) is structurally and transcriptionally intact in polycythemia vera.
    Asimakopoulos FA; Hinshelwood S; Gilbert JG; Delibrias CC; Göttgens B; Fearon DT; Green AR
    Oncogene; 1997 Mar; 14(10):1215-22. PubMed ID: 9121771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial polycythemia due to truncations of the erythropoietin receptor.
    Forget BG; Degan BA; Arcasoy MO
    Trans Am Clin Climatol Assoc; 2000; 111():38-44; discussion 44-5. PubMed ID: 10881330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera.
    Ugo V; Marzac C; Teyssandier I; Larbret F; Lécluse Y; Debili N; Vainchenker W; Casadevall N
    Exp Hematol; 2004 Feb; 32(2):179-87. PubMed ID: 15102479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Bcl-x in erythroid precursors from patients with polycythemia vera.
    Silva M; Richard C; Benito A; Sanz C; Olalla I; Fernández-Luna JL
    N Engl J Med; 1998 Feb; 338(9):564-71. PubMed ID: 9475763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias.
    Kralovics R; Indrak K; Stopka T; Berman BW; Prchal JF; Prchal JT
    Blood; 1997 Sep; 90(5):2057-61. PubMed ID: 9292543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dependence for the proliferative response to erythropoietin on an established erythroid differentiation program in a human hematopoietic cell line, UT-7.
    Nicolis S; Ottolenghi S; Papayannopoulou T; Baiocchi M; Migliaccio G; Adamson J; Migliaccio AR
    Exp Hematol; 1993 May; 21(5):665-70. PubMed ID: 8513868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-erythropoietin (EPO) receptor monoclonal antibodies distinguish EPO-dependent and EPO-independent erythroid progenitors in polycythemia vera.
    Fisher MJ; Prchal JF; Prchal JT; D'Andrea AD
    Blood; 1994 Sep; 84(6):1982-91. PubMed ID: 8081000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of polycythemia in a child with a unique erythropoietin receptor mutation in a family with autosomal dominant primary polycythemia.
    Kralovics R; Sokol L; Prchal JT
    J Clin Invest; 1998 Jul; 102(1):124-9. PubMed ID: 9649565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary familial polycythemia: a frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin.
    Sokol L; Luhovy M; Guan Y; Prchal JF; Semenza GL; Prchal JT
    Blood; 1995 Jul; 86(1):15-22. PubMed ID: 7795221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of clinical course in patients with idiopathic erythrocytosis by endogenous erythroid colony assay but not by serum erythropoietin levels.
    Shih LY; Lee CT; Ou YC
    Exp Hematol; 1997 Apr; 25(4):288-92. PubMed ID: 9131002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro erythropoiesis in polycythemia vera and other myeloproliferative disorders.
    Weinberg RS
    Semin Hematol; 1997 Jan; 34(1):64-9. PubMed ID: 9025164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors.
    Perrotta S; Cucciolla V; Ferraro M; Ronzoni L; Tramontano A; Rossi F; Scudieri AC; Borriello A; Roberti D; Nobili B; Cappellini MD; Oliva A; Amendola G; Migliaccio AR; Mancuso P; Martin-Padura I; Bertolini F; Yoon D; Prchal JT; Della Ragione F
    PLoS One; 2010 Aug; 5(8):e12015. PubMed ID: 20700488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.